S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Newron PharmaceuticalsMustang BioNuCanaAraviveCELYAD SA/ADR
SymbolOTCMKTS:NWPHFNASDAQ:MBIONASDAQ:NCNANASDAQ:ARAVNASDAQ:CYAD
Price Information
Current Price$7.50$2.63$5.28$5.89$7.68
52 Week RangeN/ABuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyBuy
Consensus Price TargetN/A$7.00$18.67$26.00$27.33
% Upside from Price TargetN/A166.16% upside253.54% upside341.80% upside255.90% upside
Trade Information
Market Cap$133.88 million$106.24 million$163.07 million$80.64 million$100.65 million
Beta0.041.761.392.41.25
Average Volume10300,392136,863154,16416,459
Sales & Book Value
Annual Revenue$7.88 millionN/AN/A$4.75 million$10,000.00
Price / Sales16.99N/AN/A18.6110,705.92
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.63 per share$1.25 per share$2.52 per share$4.71 per share$3.67 per share
Price / Book2.07N/AN/A1.252.09
Profitability
Net Income$-22,640,000.00$-46,390,000.00$-27,340,000.00$-18,220,000.00$-32,070,000.00
EPS($1.27)($1.29)($0.84)($1.57)($2.57)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio15.63N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/A-86.70%-30.37%-32.47%N/A
Return on Assets (ROA)N/A-61.77%-27.90%-25.70%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.27%0.01%0.11%0.07%
Current RatioN/A8.12%10.54%13.73%3.59%
Quick RatioN/A8.12%10.54%13.73%3.59%
Ownership Information
Institutional Ownership PercentageN/A21.61%41.76%42.87%7.84%
Insider Ownership PercentageN/A1.70%N/A39.80%N/A
Miscellaneous
Employees24382114N/A
Shares Outstanding17.85 million42.84 million32.23 million15.02 million13.94 million
Next Earnings Date6/4/2020 (Estimated)5/8/2020 (Estimated)5/12/2020 (Estimated)5/13/2020 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel